NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. (Q52948912)

9 May 2018

title

NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers. (English)

1 reference

9 May 2018

Erratum to: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.

1 reference

1 reference

1 reference

corrigendum / erratum

0 references

author

Kazuyuki Matsushita

5

1 reference

9 May 2018

author name string

Yoko Oshima

1

1 reference

9 May 2018

Hideaki Shimada

2

1 reference

9 May 2018

Satoshi Yajima

3

1 reference

9 May 2018

Tatsuki Nanami

4

1 reference

9 May 2018

Fumio Nomura

6

1 reference

9 May 2018

Osamu Kainuma

7

1 reference

9 May 2018

Nobuhiro Takiguchi

8

1 reference

9 May 2018

Hiroaki Soda

9

1 reference

9 May 2018

Takeshi Ueda

10

1 reference

9 May 2018

Toshihiko Iizasa

11

1 reference

9 May 2018

Naoto Yamamoto

12

1 reference

9 May 2018

Hiroshi Yamamoto

13

1 reference

9 May 2018

Matsuo Nagata

14

1 reference

9 May 2018

Sana Yokoi

15

1 reference

9 May 2018

Masatoshi Tagawa

16

1 reference

9 May 2018

Seiko Ohtsuka

17

1 reference

9 May 2018

Akiko Kuwajima

18

1 reference

9 May 2018

Akihiro Murakami

19

1 reference

9 May 2018

Hironori Kaneko

20

1 reference

9 May 2018

publication date

24 April 2015

1 reference

9 May 2018

Journal of Gastroenterology

published in

1 reference

9 May 2018

volume

51

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

30-34

1 reference

9 May 2018

Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Serum autoantibody measurement for the detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

NY-ESO-1 antibody as a novel tumour marker of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

Impact of serum biomarkers on esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1078-8

NY-ESO-1 expression and immunogenicity in prostate cancer patients

21 January 2018

1 reference

12 December 2020

Prognostic Significance of CYFRA 21-1 in Patients with Esophageal Squamous Cell Carcinoma

1 reference

12 December 2020

Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer

1 reference

12 December 2020

Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

1 reference

12 December 2020

Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group

1 reference

12 December 2020

Serum p53 antibodies as early markers of lung cancer

1 reference

12 December 2020

Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer.

1 reference

12 December 2020

10.1007/S00535-015-1078-8

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

25906289

1 reference

9 May 2018